- Home
- PHIO vs HSDT Comparison
PHIO vs HSDT Comparison
Compare PHIO & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHIO | HSDT |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3M | 165.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PHIO | HSDT |
|---|---|---|
| Price | $1.07 | $2.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $10.67 | N/A |
| AVG Volume (30 Days) | 374.1K | ★ 663.7K |
| Earning Date | 11-13-2025 | 11-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $941,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $75.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 87.45 |
| 52 Week Low | $0.97 | $2.62 |
| 52 Week High | $9.79 | $1,200.00 |
Technical Indicators
Market Signals| Indicator | PHIO | HSDT |
|---|---|---|
| Relative Strength Index (RSI) | 29.23 | 32.12 |
| Support Level | $1.04 | $2.62 |
| Resistance Level | $1.20 | $4.32 |
| Average True Range (ATR) | 0.09 | 0.39 |
| MACD | 0.01 | 0.08 |
| Stochastic Oscillator | 5.18 | 18.68 |
Price Performance
Historical ComparisonAbout PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
About HSDT Helius Medical Technologies Inc. (DE)
Solana Co is a publicly listed digital asset treasury established in partnership with Pantera and Summer Capital. The company is dedicated to acquiring Solana (SOL) and aims to maximize SOL per share by strategically leveraging capital market opportunities and on-chain activities. Through this model, Solana Company provides public market investors with efficient and direct exposure to Solana's long-term growth potential.